be greatly increased in Crohn's disease. This paper describes a preliminary visual assessment and a subsequent estimation by scanning densitometry of the presence of lactosylceramide in inflammatory bowel disease.
Methods

PATIENTS
A total of 65 patients (57 children, eight adults) were studied, 32 provided samples for an initial visual assessment of lipid content and 33 for an objective study using scanning densitometry. These were divided into four clinical categories as shown in the BX=biopsy; RESEC= resection; TI =terminal ileum; LC= left colon; RC= right colon; RM= rectum.
using diagnoses made from a combination of clinical, radiological, endoscopic, and histological criteria.'
All patients were examined endoscopically to investigate clinical symptoms compatible with inflammatory bowel disease, and a provisional diagnosis could sometimes be made from the site and appearance of inflammation.
A final diagnosis is usually made from a histological examination of endoscopic biopsies. Positive stigmata of ulcerative colitis are mucosal crypt distortion and crypt abscesses, mucus depletion, and a uniformity of inflammation. The lesion in Crohn's disease, however, characteristically consists of patchy, focal inflammation, which may be transmural, with non-caseating granulomata in 40-70% of cases.5 4 (Fig. lb) . Figure 2 shows the accumulated data from our initial study of 32 patients. Lactosylceramide was not detected in extracts from the control patients nor from two cases of ulcerative colitis. The majority of samples from patients with ulcerative colitis showed a 'faintly present' lactosylceramide double spot whereas in nine of the 10 cases of Crohn's disease the double spot was 'strongly present'. All samples from the terminal ileum in Crohn's disease showed strongly present spots; the faintly present sample came from the left colon.
Lactosylceramide was not detected by chromatography of lipid extracts from uninvolved areas of the bowel in patients with Crohn's disease nor from patients with coeliac disease nor from those cases with microscopic colitis. The LC/PE ratio provided by scanning densitometry, was plotted for each of the 33 patients after breaking the code to determine the appropriate diagnostic category (Fig. 3) . The bowel disease: a biochemical study. 
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